ASCO: Immune Therapy Wins Praise

CHICAGO (MedPage Today) -- A fifth of heavily pretreated patients with advanced cancers responded to a monoclonal antibody that blocks a tumor's ability to hide from the immune system, a preliminary clinical study showed.
Source: MedPage Today Pulmonary - Category: Respiratory Medicine Source Type: news